After the GSEA pathway enrichment analysis, the IL2-STAT5 pathway was enriched by the higher expression of RUNX1 and IFNGR2, which were involved in cell proliferation, migration, invasion, and tumor immunity. The gene discussed is IL2; the disease is neoplasm.